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The correct temporal regulation of mitosis underpins genomic stability because it ensures 22 
the alignment of chromosomes on the mitotic spindle that is required for their proper 23 
segregation to the two daughter cells. Crucially, sister chromatid separation must be 24 
delayed until all the chromosomes have attached to the spindle; this is achieved by the 25 
Spindle Assembly Checkpoint (SAC) that inhibits the Anaphase Promoting 26 
Complex/Cyclosome (APC/C) ubiquitin ligase. In many species the first embryonic M-phase 27 
is significantly prolonged compared to the subsequent divisions, but the reason behind this 28 
has remained unclear. Here, we show that the first M-phase in the mouse embryo is 29 
significantly extended due to a delay in APC/C activation. Unlike in somatic cells, where the 30 
APC/C first targets cyclin A2 for degradation at nuclear envelope breakdown (NEBD), we find 31 
that in zygotes cyclin A2 remains stable for a significant period of time after NEBD. Our 32 
findings that the SAC prevents cyclin A2 degradation, whereas over-expressed Plk1 33 
stimulates it, support our conclusion that the delay in cyclin A2 degradation is caused by low 34 
APC/C activity.  As a consequence of delayed APC/C activation cyclin B1 stability in the first 35 
mitosis is also prolonged, leading to the unusual length of the first M-phase.  36 
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Introduction 45 
The time between NEBD and the onset of anaphase is one of the most important periods for 46 
genomic stability as the cell must ensure that all the chromosomes are attached to the 47 
mitotic spindle before sister chromatids separate. This is achieved by regulating the activity 48 
of the key ubiquitin-ligase in mitosis, APC/C. In a typical mitotic division, the APC/C is 49 
activated at NEBD and one of its first substrates is cyclin A21,2. Cyclin A2 is required for cells 50 
to enter M-phase and it is targeted by the APC/C even though the SAC is active, monitoring 51 
unattached chromosomes3,4, and generating the Mitotic Checkpoint Complex (MCC) that 52 
inhibits the APC/C. Cyclin A2 can be degraded when the SAC is active because it can 53 
compete with the MCC component, BubR1, to bind Cdc205. The cyclin A2-Cdc20 complex 54 
then binds to the APC/C through a Cks protein6,7. This mode of recognition allows cyclin A2 55 
to be preferentially ubiquitylated by the APC/C over securin and cyclin B1, when APC/C 56 
activity is limited8.  57 
By contrast, the timing of cyclin B1 and securin degradation is controlled by the SAC, which 58 
prevents the APC/C from recognising cyclin B1 and securin by inactivating Cdc20. One 59 
molecule of Cdc20 is incorporated into a complex with the Mad2, BubR1 and Bub3 proteins 60 
to form the MCC that itself can inhibit a second molecule of Cdc209-13. Once all the 61 
chromosomes have attached correctly to the microtubules of the spindle through their 62 
kinetochores, the SAC is inactivated and Cdc20 is released to activate the APC/C against 63 
cyclin B1 and securin14,15, leading to the activation of separase and subsequently M-phase 64 
exit. The SAC ensures that sister chromatids will segregate to opposite spindle poles once 65 
the cohesion complexes are cleaved by separase.  66 
The first mitotic division is highly unique as it is markedly longer than subsequent divisions 67 
in many species, including mouse16,17, Xenopus18,19, sea urchins and nematodes19. In mouse 68 
embryos the first mitosis lasts for 90-120 min, whereas the second lasts only 60-80 min16,17. 69 
The human first embryonic mitosis is also very long (approximately 2,5-3hrs20-24), and 70 
although there are no published data on the length of the second embryonic mitosis, some 71 
observations confirm that it tends to be markedly shorter (R. Milewski, J. Czerniecki, S. 72 
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Wołczyński, unpublished data). By comparison, in somatic cells the length of M-phase varies 73 
between 30 and 60 min, depending on the cell type and on the length of the SAC-regulated 74 
prometaphase, i.e. the period when the spindle and correct kinetochore-microtubule 75 
attachments are formed25-29.  76 
One of the mechanisms that might prolong the first embryonic M-phase involves Emi2, an 77 
inhibitor of Cdc2030-32. The accumulation of Emi2 in metaphase II oocytes inhibits APC/C and 78 
thus maintains high levels of cyclin B1 and securin prior to fertilization33,34.  Sperm 79 
penetration releases the oocyte from the Emi2-induced M-phase arrest by triggering 80 
phosphorylation of Emi2 by Ca2+/calmodulin dependent kinase II (CaMKII) and Plk1, which 81 
subsequently targets it for degradation30,35-37. Emi2 protein reappears in zygotes and it has 82 
been hypothesised that this contributes to the prolonged zygotic M-phase32,38. Alternatively, 83 
zygotic M-phase has also been proposed to be prolonged by a pool of stable cyclin A2 that 84 
inhibits efficient ubiquitination of cyclin B1 and securin by the APC/C39,40.  85 
Here, we have investigated how the APC/C is regulated at the 1- to 2-cell transition in 86 
mouse embryos by assaying the degradation of cyclin A2 and cyclin B1. We find that, unlike 87 
in somatic cells, the APC/C does not appear to be activated at NEBD because we find cyclin 88 
A2 is stable in cells for over 30 min after NEBD, and cyclin B1 is stable for more than 45 min.  89 
We show that this delay in APC/C activation is most likely not caused by residual Emi2 but 90 
instead depends on Plk1 activity. Moreover, our experiments reveal that cyclin A2 91 
degradation is repressed by the SAC. Thus, we find that the prolonged first mammalian 92 
mitosis correlates with an unusual behaviour of the APC/C. 93 
Results  94 
Spatiotemporal dynamics of cyclin A2 and cyclin B1 in mouse zygotes 95 
To determine how the very first embryonic M-phase is regulated, we assayed the 96 
spatiotemporal dynamics of cyclin A2 and B1. To this end, we injected zygotes or 2-cell 97 
embryos with synthetic mRNAs encoding either cyclin A2 tagged with YFP (cyclin A2-YFP), or 98 
cyclin B1 tagged with YFP or with Ruby (cyclin B1-YFP and cyclin B1-Ruby) and filmed their 99 
development through the first two mitotic divisions. We found that cyclin A2 was localized 100 
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in zygotic pronuclei during interphase, released into the cytoplasm during NEBD, degraded 101 
before the onset of anaphase, then resynthesized and imported into nuclei after the 102 
completion of division (Fig. 1a, Supplementary Video S1). In 2-cell embryos cyclin A2 103 
degradation started at NEBD, exactly as in somatic cells1,2, but in zygotes it was significantly 104 
delayed (median of 39.0 min post NEBD, p<0.001) and subsequently proceeded at a slow 105 
rate (Fig. 1a,c, Table 1). The observation that cyclin A2 remained stably expressed at a high 106 
level for over 30 min after NEBD in zygotes indicated that activation of APC/C was delayed 107 
rather than partially activated. In the latter situation, cyclin A2 degradation would be 108 
initiated at the NEBD but proceed with slower kinetics.    109 
Assaying cyclin B1 showed that it was excluded from the nucleus for most of interphase and 110 
imported into the nucleus during prophase, approximately 30 min before NEBD. At NEBD 111 
cyclin B1 was released into the cytoplasm and bound the mitotic apparatus (Fig. 1b, 112 
Supplementary Video S2). We found that cyclin B1 was degraded at a similar rate during the 113 
first and second mitotic divisions (Fig. 1d), but, as with cyclin A2, the onset of cyclin B1 114 
degradation in the first mitotic division was significantly delayed in comparison to the 115 
second mitotic division (medians of 48.0 and 18.0 min from NEBD, respectively, p<0.001, 116 
Fig. 1b,d, Table 2). The delay in the degradation of cyclin A2 and cyclin B1 corresponded to 117 
the prolonged duration of the whole M-phase in zygotes when compared to 2-cell embryos 118 
(medians of 111.0 and 57.0 min, respectively, p<0.001, for cyclin A2-YFP embryos, and 96.0 119 
and 76.5 min, p<0.001, for cyclin B1-Ruby embryos, Table 1,2). However, when we tested 120 
the correlation between the onset time of cyclin degradation and the duration of M-phase, 121 
we found that only the delay in cyclin B1 degradation, and not in cyclin A2 degradation, 122 
correlated with the length of M-phase (R=0.67, p<0.001).  Taken together these results 123 
indicate that the prolonged duration of the first mitotic division might be caused by the 124 
delayed degradation of cyclin B1.  125 
Delayed degradation of cyclin A2 does not affect the timing of cyclin B1 degradation 126 
As late degradation of cyclin A2 did not seem to correlate with prolongation of the first 127 
embryonic M-phase, we directly addressed whether the high levels of cyclin A2 in zygotes 128 
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after NEBD might reduce the ability of the APC/C to ubiquitylate cyclin B1 and delay its 129 
degradation. To test this hypothesis, we examined the effect of over-expressing cyclin A2 on 130 
the rate of cyclin B1 degradation. To this end, zygotes were injected with mRNA encoding 131 
cyclin B1-Ruby and various concentrations (0.0-0.4 μg/μl) of mRNA encoding cyclin A2-YFP. 132 
The increasing concentrations of mRNA translated into increasing amounts of cyclin A2 133 
protein as judged by an increase in fluorescence signal (Fig. 2a). We found that 134 
overexpressing cyclin A2-YFP did not change the onset of cyclin B1-Ruby degradation (Fig. 135 
2a, Table 2). We next followed degradation of cyclin B1-Ruby and cyclin A2-YFP 136 
simultaneously in zygotes. This revealed that cyclin B1-Ruby started to be degraded on 137 
average 3 min after cyclin A2 degradation, and at that time the level of cyclin A2 had only 138 
decreased on average by 0.7% (Fig. 2b). These results indicated that the delay in cyclin B1 139 
degradation was not due to the late degradation of cyclin A2. 140 
The SAC controls both cyclin B1 and cyclin A2 degradation 141 
In somatic cells a strong SAC signal does not prevent cyclin A2 degradation, although it slows 142 
it down41, but it does prevent cyclin B1 degradation8,14. Since degradation of both cyclin A2 143 
and B1 was delayed in the first embryonic M-phase, we wished to investigate whether the 144 
SAC was responsible for this. To test this hypothesis, we determined the effect of inhibiting 145 
the Mps1 kinase, an essential activator of the SAC42,43, on the dynamics of cyclin A2 and 146 
cyclin B1 degradation. We injected zygotes with cyclin A2-YFP or cyclin B1-Ruby and assayed 147 
their development in the presence of reversine, an Mps1 inhibitor42. We found that 148 
inhibiting the SAC shortened the period between NEBD and the onset of cyclin B1-Ruby 149 
degradation (to the median of 39 min, p<0.05, Fig. 3a, Table 2). Similarly, reversine 150 
accelerated the onset of securin-GFP degradation (from the median of 36 min to 24 min, 151 
p<0.001; Supplementary Fig. S1a, Supplementary Table S1). Unlike in somatic cells, ablating 152 
the SAC in zygotes advanced the timing of cyclin A2-YFP degradation (to the median of 3 153 
min, p<0.001, Fig. 3b). We concluded that the SAC affects the timing of the cyclin B1 and A2 154 
degradation and thus might be partially responsible for the prolonged first mouse 155 
embryonic M-phase. Inactivation of the SAC during the first division did not, however, 156 
shorten the time between NEBD and the onset of cyclin B1 or cyclin A2 degradation to the 157 
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length comparable with the period observed in the subsequent division (p<0.001 and p<0.05 158 
respectively, Table 1,2). This indicated that there was an additional mechanism regulating 159 
the onset of cyclin B1 and A2 degradation and, in consequence, the length of the first M-160 
phase. 161 
Emi2 is not involved in regulation of the first embryonic M-phase  162 
The first mechanism we considered was APC/C inhibition by maternal Emi2, which is 163 
responsible for maintaining oocytes in metaphase II. It had previously been suggested that 164 
prolongation of the first embryonic M-phase was caused by the persistence of Emi2 that is 165 
resynthesized in zygotes after its degradation triggered by fertilisation32. To address 166 
whether Emi2 was responsible for the delay in cyclin degradation and the prolonged zygotic 167 
M-phase, we depleted Emi2 with specific morpholinos (Emi2 MO), which had been shown to 168 
block the translation of Emi2 mRNA33. Since Emi2 is required to inhibit the APC/C and 169 
maintain oocytes in metaphase II, we assayed the effectiveness of the Emi2 MO to deplete 170 
Emi2 by co-injecting Emi2 MO with cyclin B1-YFP into metaphase II oocytes and measured 171 
the level of cyclin B1-YFP fluorescence and oocyte activation. We found that 75% of oocytes 172 
injected with Emi2 MO (33/44), but only 9% (2/22) oocytes injected with a control MO (Emi2 173 
MO with 5 mismatched pairs of nucleotides, Emi2 5-MP MO) underwent activation within 174 
24 hrs of injection (Supplementary Fig. S2a). Moreover, there was an abrupt decrease in 175 
cyclin B1-YFP 12 hrs after microinjection of Emi2 MO, whereas in oocytes co-injected with 176 
Emi2 5-MP MO cyclin B1 remained stable (Supplementary Fig. S2b). These results 177 
demonstrated that we could efficiently deplete Emi2 through this approach. We injected 178 
Emi2 MO into very early zygotes, 2h post fertilization and well before pronuclei formation, 179 
at the time, when Emi2 protein is completely degraded33. This ensured that the morpholinos 180 
were injected in time to prevent re-synthesis of Emi2 after its degradation at meiotic 181 
exit32,33. We found that zygotes injected with Emi2 MO behaved exactly as the control-182 
injected zygotes with no shortening of the M-phase and no difference in the timing of cyclin 183 
B1 degradation (medians of 40 and 45 min, respectively, p>0.05, Fig. 4a). 184 
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As a further test of the potential role of Emi2 in prolonging M-phase, we depleted Emi2 by 185 
siRNA.  To this end, we injected GV stage oocytes with mRNA encoding securin-GFP together 186 
with siRNA specific for Emi2 or control siRNA, allowed them to mature in vitro until 187 
metaphase II, then activated them parthenogenetically and assayed them through the first 188 
embryonic division. Emi2 depletion did not accelerate the onset of securin degradation 189 
(Supplementary Fig. S3a,b), even though  the efficiency of Emi2 siRNA was confirmed by its 190 
ability to release metaphase II arrest in injected oocytes (Supplementary Fig. S3c). Taken 191 
together, these results show that Emi2 is unlikely to be responsible for the delay in 192 
degradation of APC/C substrates during the first embryonic M-phase. 193 
Plk1 controls both cyclin B1 and cyclin A2 degradation in a SAC-independent manner  194 
We then tested the possibility that Plk1 might be responsible for the delay in cyclin 195 
degradation because it is important for the full activation of the APC/C44-46. Moreover, Plk1 196 
is essential for the completion of the first embryonic cell cycle in the mouse47,48. To examine 197 
whether Plk1 might be involved in regulating cyclin B1 and A2 turnover in the first M-phase 198 
in mouse, we injected zygotes with mRNAs encoding wt Plk1 and cyclins (A2 or B1) and then 199 
assayed their development. We found that over-expression of wt Plk1-YFP shortened the 200 
period between NEBD and the onset of cyclin B1-Ruby degradation to the length typical for 201 
the second M-phase (to a median of 28.5 min, p<0.001 when compared to the first M-phase 202 
and p>0.05 when compared to the second M-phase; Fig. 4b, Table 2). The duration of the 203 
whole M-phase was also shortened accordingly (to a median of 78.0 min, p<0.001 when 204 
compared to the first M-phase and p>0.05 when compared to the second M-phase, Table 205 
2). Over-expression of an inactive, kinase dead Plk1 (kd Plk1-YFP) did not affect the 206 
degradation of cyclin B1 (Fig. 4b, Table 2), indicating that the observed acceleration of cyclin 207 
B1 degradation required Plk1 activity. Over-expression of wt Plk1-TagRFP also advanced the 208 
onset of securin degradation (to a median of 27.0 min, p<0,05; Supplementary Fig. S1b, 209 
Supplementary Table S1). Remarkably, we found that although Plk1 is not required for cyclin 210 
A2 to be degraded in somatic cells49, over-expressing Plk1-TagRFP significantly accelerated 211 
the onset of cyclin A2-YFP degradation in zygotes (to a median of 15 min post NEBD, p<0.05) 212 
(Fig. 4c, Table 1), although it still occurred on average later than in 2-cell embryos (p<0.05, 213 
  
 
 
 
9
Table 1).  214 
As a further test of whether Plk1 was involved in regulating the first embryonic M-phase, we 215 
inhibited Plk1 with the small molecule inhibitor BI253649 and assessed zygotic division by 216 
time-lapse microscopy. This revealed that BI2536 significantly delayed the onset of cyclin B1 217 
degradation (to a median of 93.0 min post NEBD, p<0.05; Fig. 4b, Table 2). Although we 218 
observed some gradual decrease of cyclin B1 in zygotes treated with BI2536, it was never 219 
sufficient to induce anaphase (Supplementary Fig. S4a). The inhibition of Plk1 also 220 
prevented the degradation of cyclin A2, which persisted at a high level for over 2h post 221 
NEBD (Fig. 4c, Table 1). We found that inhibiting Plk1 activity did not interfere with the 222 
formation of a bi-polar spindle, in agreement with a recent report48. However, we found 223 
that the spindle gradually deteriorated during the prolonged M-phase arrest; specifically the 224 
spindle poles became less focused over time and displayed increased numbers of astral 225 
microtubules, and in some cases chromosomes were displaced from the metaphase plate 226 
(Supplementary Fig. S4a).  227 
To address whether Plk1 altered the length of the first M-phase by altering SAC activity, we 228 
asked whether reversine could override the zygotic M-phase arrest induced by Plk1 229 
inhibition. We found that neither reversine, nor injection of mRNA encoding a dominant 230 
negative Mad2 (dn Mad2), was able to release zygotes from a BI2536-induced M-phase 231 
arrest (Supplementary Fig. S4b). Moreover, reversine was not able to counteract the 232 
BI2536-induced delay in cyclin B1 degradation (Fig. 4d, Table 2).  233 
Finally, since our results indicated that Plk1 activity might be limiting in the first M-phase of 234 
the mouse embryo, we investigated whether the amount of active Plk1 (i.e. Plk1 235 
phosphorylated at Thr210) differs between M-phase zygotes and 2-cell embryos. 236 
Quantitative analysis of the intensity of phospho-Plk1 (pPlk1) immunostaining indicated that 237 
active Plk1 was slightly more abundant in M-phase 2-cell embryos than in M-phase zygotes, 238 
although the difference did not reach statistical significance (p=0.058; Supplementary Fig. 239 
S5a,b). Interestingly, we observed that there was a subtle, but potentially important, 240 
difference in pPlk1 localization in 1- and 2-cell stage embryos. In both the first and the 241 
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second M-phase pPlk1 localized to the spindle poles and chromosomes; however, in 2-cell 242 
embryos it strongly accumulated on kinetochores, whereas in zygotes its chromosomal 243 
distribution was more diffuse (Supplementary Figure S5c). 244 
Taken together these results indicate that the degradation of cyclins B1 and A2, and in 245 
consequence the prolonged first M-phase, is regulated by a Plk1-dependent mechanism. We 246 
propose that a difference in the localization of active Plk1 might potentially be involved in 247 
prolongation of the first embryonic M-phase in the mouse.   248 
Discussion 249 
The first embryonic mitosis in a number of species is strikingly longer than the subsequent 250 
embryonic mitoses and mitosis in somatic cells19,50. Indeed, the first zygotic M-phase is 251 
unique because during this period two sets of chromosomes, enclosed in separate nuclei, 252 
need to form a single metaphase plate. This process is more complicated than its equivalent 253 
in a typical mononuclear somatic cell, and therefore most likely more time is required to 254 
ensure appropriate chromosome-spindle connections. It appears plausible to us that this is 255 
the biological purpose of the prolonged first zygotic M-phase, and particularly the period 256 
between NEBD and cyclin B1 degradation.  257 
Here, we have uncovered atypical APC/C behaviour in the first mitotic division that appears 258 
to be responsible for this extended M-phase. Our analysis of the spatiotemporal dynamics 259 
of cyclin A2 and cyclin B1 indicates that length of the first M-phase is likely a consequence of 260 
delayed APC/C activation. We find that cyclin A2 starts to be degraded in zygotes over 30 261 
min after NEBD, in striking contrast to 2-cell embryos or somatic cells where cyclin A2 begins 262 
to be degraded at NEBD. The degradation of cyclin B1 and securin in zygotes is also 263 
significantly delayed in comparison to mitosis in 2-cell embryos, and to somatic cells8,14. 264 
Although it has been hypothesized that the stable pool of cyclin A2 is responsible for the 265 
prolonged M-phase in zygotes39,40, our results do not support this idea because we find that 266 
cyclin B1 starts to be degraded when the levels of cyclin A2 are still very high. Furthermore, 267 
overexpressing cyclin A2 does not delay the onset of cyclin B1 degradation. However, in 268 
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accordance with published data1,2,51  we observed that overexpression of cyclin A2 disturbs 269 
progression of anaphase and cytokinesis.  270 
Our experiments provide evidence that the SAC regulates APC/C activity towards cyclin A2 271 
in the first M-phase in mouse because inhibiting the SAC both advances and accelerates the 272 
degradation of cyclin A2 (and B1). However, our results also indicate that SAC activity is not 273 
solely responsible for the prolongation of the zygotic M-phase since inhibiting the SAC 274 
accelerated the onset of cyclin degradation by only approximately 10-20 min. This agrees 275 
with earlier work showing that SAC proteins, such as Mad2 leave, the kinetochores in 276 
zygotes within approximately 20 min of NEBD17, and a similar delay in cyclin B1 degradation 277 
is caused by the SAC in somatic cells27,29. Thus, there must be another mechanism involved 278 
in the delay in degradation of cyclins A2 and B1, and as a result, the prolongation of zygotic 279 
M-phase.  280 
Our evidence implicates Plk1 as the additional factor responsible for the first mitotic delay. 281 
Plk1 activity appears to be a limiting factor because overexpression of Plk1 accelerates the 282 
onset of cyclin A2 and B1 degradation, even though in somatic cells Plk1 activity is not 283 
required for the APC/C to target cyclin A2 at NEBD49,52. Moreover, Plk1 overexpression 284 
shortens the period between NEBD and the onset of cyclin B1-Ruby degradation to the 285 
length typical for the second embryonic mitosis.  We show that Plk1 does not act exclusively 286 
through the SAC, since ablation of the SAC does not rescue the delay caused by Plk1 287 
inhibition. Plk1 is also unlikely to act through Emi2 since the injection of Emi2-specific 288 
morpholinos or siRNAs did not accelerate cyclin B1 or securin degradation during the first 289 
embryonic division. However, we cannot completely exclude the possibility that in zygotic 290 
M-phase even a very small amount of Emi2 that potentially may remain in the cell after MO- 291 
or siRNA-induced depletion is sufficient to inhibit APC/C activity. Indeed, the role of Emi2 in 292 
the first mitotic divisions is currently debated in Xenopus embryos34,53. Instead, our 293 
evidence would be congruent with a role for Plk1 in activating the APC/C in embryonic 294 
divisions through direct phosphorylation of the APC/C complex45,46,52,54.  295 
 296 
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If Plk1 is indeed a limiting factor in the zygotic M-phase, then it should either be expressed 297 
at lower levels in zygotes, or be differently regulated.  Analysis of transcriptomic data 298 
available in the DBTMEE database (RNA-seq Ver2_FPKM collection, http://dbtmee.hgc.jp/)55 299 
indicates that Plk1 mRNA expression is higher in zygotes than in 2-cell embryos, but we find 300 
that the amount of active Plk1 is comparable – with a tendency to be lower - between M-301 
phase zygotes and 2-cell embryos. Comparing the expression of Plk1 activators / inhibitors 302 
also does not reveal a clear difference between these two stages: some transcripts are more 303 
abundant in zygotes, others in 2-cell embryos. Alternatively, the difference between the 304 
mode of Plk1 action in the first and the second embryonic divisions may relate to the 305 
distribution of active Plk1: in contrast to 2-cell embryos, in zygotes, pPlk1 does not 306 
accumulate very effectively on kinetochores. 307 
Taken together, we conclude that the APC/C has reduced activity in the first embryonic 308 
division that extends the first M-phase. As a consequence we find that cyclin A2 degradation 309 
in the first mitosis is atypical, resembling the way in which cyclin B1 is controlled in somatic 310 
cells, because its degradation is regulated by both SAC and Plk1 activities. Our observations 311 
shed new light on the molecular machinery controlling the unusual length of the first 312 
embryonic division 313 
Methods 314 
Embryo collection and culture 315 
All experimental procedures applied to animals were approved by the Home Office (UK) or 316 
by the Local Ethical Committe no. 1 (Warsaw, Poland), and were performed in compliance 317 
with the national regulations. Mouse F1 (C57Bl6 x CBA) females were superovulated by an 318 
intraperitoneal injection of 10 IU of pregnant mare serum gonadotrophin (PMSG, Intervet) 319 
followed 48 hrs later by 10 IU of human chorionic gonadotrophin (hCG, Intervet) and mating 320 
with F1 males. Zygotes and 2-cell embryos were recovered from oviducts into M2 medium 321 
16-20 hrs and 44 hrs after hCG injection, respectively. MII oocytes were recovered 15 hrs 322 
post hCG injection from oviducts of unmated females into M2 medium. GV oocytes were 323 
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recovered from ovaries 48 hrs after the PMSG injection into M2 medium supplemented with 324 
150 μg/ml dibutyryl cyclic AMP (dbcAMP, Sigma-Aldrich). 325 
Microinjections and live imaging of embryos 326 
Constructs encoding cyclin B1 tagged with YFP or Ruby (cyclin B1-YFP, cyclin B1-Ruby), cyclin 327 
A2 tagged with YFP (cyclin A2-YFP), Plk1 tagged with YFP or TagRFP (wt Plk1-YFP, wt Plk1-328 
TagRFP), kinase dead version of Plk1 tagged with YFP (kd Plk1-YFP), dominant negative 329 
version of Mad2 (dn Mad2) and securin tagged with GFP (securin-GFP) were cloned into 330 
pBluescript RN3P vector and mRNA was synthesized from the T3 promotor using mMessage 331 
mMachine T3 kit (Ambion), as described previously56. A construct encoding histone 2B 332 
tagged with RFP (H2B-RFP) was cloned into pGEMHE vector and synthesized from the T7 333 
promotor using mMessage mMachine T7 kit (Ambion). mRNAs (needle concentration 0.025 334 
μg/μl for H2B-RFP, 0.07 μg/μl for cyclin B1-Ruby, 0.07 μg/μl for cyclin A2-YFP, 0.2 μg/μl for 335 
cyclin B1-YFP, wt Plk1-YFP and kd Plk1-YFP, 0.35 μg/μl for securin-GFP, 0.7 μg/μl for Plk1-336 
TagRFP, 0.8 μg/μl dn Mad2) were injected into a zygote or one blastomere of a 2-cell stage 337 
embryo and injected embryos were subsequently cultured in KSOM (Speciality Media, 338 
Millipore) for approximately 6 hrs to allow for  sufficient protein expression. In some 339 
experiments oocytes or embryos were injected with 25μM siRNA (Sigma-Aldrich) or 2mM 340 
morpholino33 (Gene Tools LLC) specific to Emi2 and with appropriate controls 341 
(Supplementary Table S2). Emi2 MO was injected into early zygotes (recovered 16 hrs post 342 
hCG) together with cyclin B1-YFP, which then were cultured for approximately 8 hrs in 343 
KSOM. Emi2 siRNA was injected with securin-GFP into GV oocytes that were afterwards 344 
allowed to mature for 16 hrs and subsequently were activated parthenogenetically by 345 
incubation in 8% ethanol for 8 min and cultured for 8 hrs in KSOM. Zygotes, 346 
parthenogenotes or 2-cell embryos were transferred into M2 medium and imaged in 11-13 347 
planes (5-6 µm apart) every 3-15 min for 12 hrs over the transition from 1- to 2-cell stage or 348 
2- to 4-cell stage. In some experiments M2 was supplemented with 500 nM reversine 349 
(Sigma-Aldrich) or 100 nM BI2536 (Axon Medchem). Imaging was performed on a 3i 350 
Intelligent Imaging Solutions spinning-disc confocal microscope, Zeiss Axiovert fluorescence 351 
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microscope or Deltavision fluorescence microscope, all equipped with environmental 352 
chambers maintaining temperature of 37.5oC.  353 
Immunostaining 354 
Embryos were fixed in 4% PFA (30 min, RT), permeabilised with 0.5% Triton-X100 (30 min, 355 
RT) and blocked with 3% BSA. Plk1 phosphorylated at Thr210 was labeled with a polyclonal 356 
rabbit antibody (ThermoFisher Scientific; dilution 1:100 in 3% BSA, overnight, 4 oC) and 357 
cyclinA2  - with a polyclonal rabbit antibody (Santa Cruz; dilution 1:50 in 3% BSA, overnight, 358 
4 oC), both followed by a secondary anti-rabbit antibody conjugated with Alexa 633 359 
(Molecular Probes, ThermoFisher Scientific; dilution 1:200 in 3% BSA, 1.5h, RT). 360 
Microtubules were stained with mouse anti-tubulin β antibody labeled with FITC (Sigma-361 
Aldrich; dilution 1:50 in 3% BSA, 1.5h, RT or overnight, 4oC) DNA was stained with Hoechst 362 
33342 dye (Molecular Probes, ThermoFisher Scientific; 100ng/µl in PBS, 30 min, RT or 363 
overnight, 4oC), propidium iodide (Sigma-Aldrich; 3 μg/ml in PBS, 30 min, RT) or 364 
chromomycin A3 (Sigma-Aldrich; 10 μg/ml, 30 min, RT or overnight, 4oC). In case of 365 
phospho-Plk1 detection, a PhosStop solution (Roche) was added to all stages of 366 
immunostaining to inhibit phosphatases.  367 
Statistical analysis 368 
In order to quantify cyclin B1 or cyclin A2 levels in embryos, projections (sums of all slices) 369 
were prepared for all imaged embryos and mean fluorescence intensity was measured for 370 
each projection over the time of recording. The intensity values were then standardized 371 
with the fluorescence intensity at the NEBD. Polynomial curves were fitted to the data and 372 
the onset of cyclin or securin degradation was established as the first time-point after NEBD 373 
when the fluorescence decrease between two subsequent measurements was at least 0.01. 374 
Statistical analyses of results were performed using Student’s t-test, chi-squared test, 375 
Spearman's rank-order correlation and Kruskal-Wallis test with a post-hoc multiple 376 
comparison of mean ranks test. 377 
 378 
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 531 
Figure legends 532 
Figure 1 533 
Spatiotemporal dynamics of cyclins A2 and B1 in mouse embryos 534 
(a) Spatiotemporal dynamics of cyclin A2-YFP in dividing zygotes. Selected images from a 535 
time-lapse recording, time shown in hours and minutes counted from the timepoint of 536 
nuclear envelope breakdown (NEBD). (b) Spatiotemporal dynamics of cyclin B1-YFP in 537 
dividing zygotes. Selected images from a time-lapse recording, time shown in hours and 538 
minutes counted from the timepoint of NEBD. (c) Quantification of cyclin A2-YFP 539 
degradation in 1- and 2-cell embryos, averaged from 30 and 37 embryos respectively. (d) 540 
Quantification of cyclin B1-Ruby degradation in 1- and 2-cell embryos, averaged from 55 and 541 
31 embryos respectively. Scale bars in (a) and (b) are 20 µm. Plots in (c) and (d) show mean 542 
values +/- standard deviation. 543 
Figure 2 544 
Role of cyclin A2 in regulation of cyclin B1 degradation 545 
(a) Quantification of cyclin B1-Ruby degradation in zygotes injected with increasing 546 
concentrations (0, 0.07 μg/μl, 0.2 μg/μl, 0.4 μg/μl) of cyclin A2-YFP mRNA, averaged from 547 
55, 41, 12 and 10 embryos respectively. Plots show mean values +/- standard deviation. 548 
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Images show representative zygotes injected with increasing concentrations of cyclin A2-YFP 549 
mRNA and the same concentration of cyclin B1 mRNA. Overexpression of cyclin A2 was 550 
confirmed by an immunostaining (the bottom panel). Scale bar is 100 μm. (b) Quantification 551 
of cyclin B1-Ruby and cyclin A2-YFP degradation in a single representative zygote.  552 
Figure 3 553 
Role of SAC in regulation of cyclin A2 and B1 degradation  554 
(a) Quantification of cyclin B1-Ruby degradation in control zygotes and zygotes treated with 555 
reversine averaged from 55 and 57 embryos respectively. (b) Quantification of cyclin A2-YFP 556 
degradation in control zygotes and zygotes treated with reversine averaged from 30 and 31 557 
embryos respectively. Plots in (a) and (b) show mean values +/- standard deviation. 558 
Figure 4 559 
Role of Emi 2 and Plk1 in the regulation of cyclin A2 and B1 degradation 560 
(a) Time between NEBD and the onset of cyclin B1-YFP degradation in zygotes injected with 561 
Emi2 MO and Emi2-5MP MO, averaged from 28 and 11 embryos respectively. The boxes 562 
show medians and the first and third quartiles. The whiskers are set at 1.5*IQR above the 563 
third and below the first quartile. Outlier values are marked with dots.  (b) Quantification of 564 
cyclin B1-Ruby degradation in control zygotes, zygotes injected with wt Plk1-YFP or kd Plk1-565 
YFP, and zygotes treated with BI2536, a Plk1 inhibitor, averaged from 55, 38, 11 and 12 566 
embryos respectively. (c) Quantification of cyclin A2-YFP degradation in control zygotes, 567 
zygotes injected with wt Plk1-TagRFP and zygotes treated with BI2536, averaged from 30, 22 568 
and 38 embryos respectively. (d) Quantification of cyclin B1-Ruby degradation in control 569 
zygotes and zygotes treated with BI2536 or BI2536 and reversine, averaged from 55, 12, and 570 
15 embryos respectively. Plots in (b)-(d) show mean values +/- standard deviation. 571 
  572 
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Table 1 573 
Mitotic timings in mouse embryos injected with cyclin A2-YFP 574 
a p<0.05, b p<0.001 comparing to control 1-cell embryos, c p<0.05, d p<0.001 comparing to 575 
reversine-treated 1-cell embryos, e p<0.05, f p<0.001 comparing to 1-cell embryos 576 
overexpressing wt Plk1 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
Experimental conditions Total no. 
Time between NEBD  
and cyclin A2 degradation      
(min; median (Q1;Q3)) 
Time between NEBD  
and anaphase  
(min;  median (Q1;Q3)) 
1-
ce
ll 
control 30 39.0 (30.0 ; 54.0) 111.0 (99.8 ; 117.0) 
reversine 31 3.0 (0.0 ; 19.5)b 99.0 (93.0 ; 108.0) 
wt Plk1 OE 22 15.0 (0.0 ; 26.3)a  108.0 (105.0 ; 117.0) 
BI2536  38 - - 
2-
ce
ll control 37 0.0 (0.0 ; 0.0)b,c,e 57.0 (51.0 ; 63.0)b,d,f 
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Table 2 591 
Mitotic timings in mouse embryos injected with cyclin B1-Ruby 592 
a p<0.001, b p<0.05 comparing to control 1-cell embryos, c p<0.001, d p<0.05 comparing to 593 
reversine-treated 1-cell embryos, evalues calculated only for embryos that completed 594 
cytokinesis (9 out of 12). 595 
 596 
 597 
 598 
 599 
Experimental conditions Total no. 
Time between NEBD  
and cyclin A2 degradation      
(min; median (Q1;Q3)) 
Time between NEBD  
and anaphase  
(min;  median (Q1;Q3)) 
1-
ce
ll 
control 55 48.0 (40.5 ; 52.5) 96.0 (87.0 ; 105.0) 
reversine 57 39.0 (30.0 ; 45.0)b 87.0 (81.0 ; 96.0) 
wt Plk1 OE 38 28.5 (24.0 ; 33.0)a 78.0 (75.0 ; 92.3)a 
kd Plk1 OE 11 45.0 (39.0 ; 51.0) 87.0 (82.5 ; 99.0) 
BI2536 12 93.0 (83.3 ; 100.5)b - 
BI2536 + reversine 15 90.0 (87.0 ; 103.5)b - 
cyclin A2 OE  
(0.07 µg/µl) 
41 48.0 (45.0 ; 51.0) 115.5 (105.8 ; 128.3)a 
cyclin A2 OE 
(0.2  µg/µl) 
12 54.0 (44.3 ; 60.8) 117.0 (111.0 ; 135)e 
cyclin A2 OE 
(0.4  µg/µl) 
10 54.0 (51.8 ; 67.5) - 
2-
ce
ll control 31 18.0 (15.0 ; 24.0)a,c 76.5 (69.8 ; 81)a,d 




